TC

TFS Capital Portfolio holdings

AUM $255M
1-Year Est. Return 32.31%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+32.31%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$308M
AUM Growth
-$65.9M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
1,028
New
Increased
Reduced
Closed

Top Buys

1 +$1.57M
2 +$1.55M
3 +$1.54M
4
NSIT icon
Insight Enterprises
NSIT
+$1.48M
5
ASTE icon
Astec Industries
ASTE
+$1.4M

Top Sells

1 +$1.91M
2 +$1.74M
3 +$1.68M
4
CBM
Cambrex Corporation
CBM
+$1.68M
5
ESND
Essendant Inc.
ESND
+$1.68M

Sector Composition

1 Healthcare 17.07%
2 Industrials 15.72%
3 Consumer Discretionary 12.74%
4 Technology 12.27%
5 Financials 7.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATVI
751
DELISTED
Activision Blizzard
ATVI
-8,079
KNL
752
DELISTED
Knoll, Inc.
KNL
-13,183
BDSI
753
DELISTED
BioDelivery Sciences International, Inc.
BDSI
-25,517
QADA
754
DELISTED
QAD Inc.
QADA
-6,901
CBB
755
DELISTED
Cincinnati Bell Inc.
CBB
-44,533
VVUS
756
DELISTED
Vivus Inc
VVUS
-17,831
TSS
757
DELISTED
Total System Services, Inc.
TSS
-9,900
EFII
758
DELISTED
Electronics for Imaging
EFII
-33,074
NAVG
759
DELISTED
Navigators Group Inc
NAVG
-3,462
ARLZ
760
DELISTED
Aralez Pharmaceuticals Inc.
ARLZ
-15,031
AFAM
761
DELISTED
Almost Family Inc
AFAM
-5,447
DMTX
762
DELISTED
Dimension Therapeutics, Inc
DMTX
-14,043
CFNL
763
DELISTED
Cardinal Financial Corp
CFNL
-9,210
HEOP
764
DELISTED
Heritage Oaks Bancorp
HEOP
-21,412
DSCI
765
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
-19,010
ATAXZ
766
DELISTED
AMERICA FIRST TAX EXEMT INV LP
ATAXZ
-42,301
SVA
767
DELISTED
Sinovac Biotech, Ltd
SVA
-26,662
STL
768
DELISTED
Sterling Bancorp
STL
-19,121
CZR
769
DELISTED
Caesars Entertainment Corporation
CZR
-10,200
GNW icon
770
Genworth Financial
GNW
$3.44B
-348,376
GPRE icon
771
Green Plains
GPRE
$1.14B
-15,807
GTE icon
772
Gran Tierra Energy
GTE
$316M
-2,719
HAIN icon
773
Hain Celestial
HAIN
$77.9M
-12,043
HALO icon
774
Halozyme
HALO
$7.89B
-33,809
HBM icon
775
Hudbay
HBM
$9.54B
-157,427